The 81st Annual Meeting of the Japanese Society of Hematology

Presentation information

Print

Morning Seminar

MS3-5 Optimal treatment with newer agents for relapsed and refractory multiple myeloma

Sun. Oct 13, 2019 7:55 AM - 8:40 AM No.5 (Tokyo International Forum, 5F Hall B5(2))

Chair: Toshihiro Miyamoto（Department of Medicine and Biosystemic Science, Kyusyu University Graduate School of Medical Science）

Sponsor: Bristol-Myers Squibb K.K.

[MS3-5] Optimal treatment with newer agents for relapsed and refractory multiple myeloma

Shigeki Ito (Hematology & Oncology, Department of Internal Medicine , Iwate Medical University School of Medicine)

Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate.Password is written on a program book.

Password